Bayesian Capital Management’s iPath Series B S&P 500 VIX Short-Term Futures ETN VXX Stock Holding History
Bought
Maintained
Sold
Other funds holding VXX
BCM
Bayesian Capital Management's VXX Position: Q1 2020 in Review
Bayesian Capital Management sold out of iPath Series B S&P 500 VIX Short-Term Futures ETN (VXX) in Q1 2020, closing a stake of 613 shares — an estimated $593K sold.
Bayesian Capital Management first reported a position in VXX in Q3 2019 and held it in 2 quarters. The position peaked at $1.79M in Q3 2019. 67 funds tracked by Wall St. Rank hold VXX as of Q1 2020.
- Bayesian Capital Management reported no remaining iPath Series B S&P 500 VIX Short-Term Futures ETN position as of Q1 2020 after selling out during the quarter.
- Bayesian Capital Management sold 613 iPath Series B S&P 500 VIX Short-Term Futures ETN shares in Q1 2020, an estimated $593K.
- Bayesian Capital Management first reported a position in iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2019 and held it in 2 quarters.
- Bayesian Capital Management's iPath Series B S&P 500 VIX Short-Term Futures ETN position peaked at $1.79M in Q3 2019.
- 67 funds tracked by Wall St. Rank held iPath Series B S&P 500 VIX Short-Term Futures ETN as of Q1 2020.
Based on Bayesian Capital Management's 13F filing for Q1 2020, filed 15 May 2020.